HNGR - Hanger estimates 12% revenue growth in FY21 revenue below analysts consensus

Hanger (NYSE:HNGR) estimates net revenues for the year ended Dec.31,2021 will be ~$1.12B (+12% Y/Y) and adj. EBITDA to be ~$118.9M (+13% Y/Y). Analysts consensus estimates for FY revenue stands at $1.13B (+13.1% Y/Y). The company’s estimated Patient Care same clinic growth rate was ~9% on a day-adjusted basis. For FY22, net revenue is seen ranging between $1.19 and $1.22B, and adj. EBITDA in a range between $127 and $132; utilizing midpoint of guidance range, revenue growth is ~7% and adj. EBITDA growth at ~9%. The company’s revenue growth includes an estimate of ~5% in same clinic revenue growth on a day adjusted basis related to its Patient Care segment. 2022 outlook includes ~$35M in revenue relating to the full year effect of acquisitions completed in 2021. Q4 and FY results are scheduled for Feb.28 release, after market close. Shares trading 1.5% down premarket.

For further details see:

Hanger estimates 12% revenue growth in FY21 revenue, below analysts consensus